Patient ID | Age/ sex | Disease status after induction | Disease status after consolidation therapy | Relapse | ||||
---|---|---|---|---|---|---|---|---|
245 | 53/F | CR | CR | / | yes | / | ||
275 | 50/F | CR | CR | yes | ||||
280 | 61/F | RD | / | |||||
/ | ||||||||
291 | 38/F | RD | / | RD | / | |||
305 | 47/M | CR | CR | yes | / | |||
320 | 40/M | CR | CR | / | ||||
349 | 39/M | CR | / | / | ||||
378 | 66/M | ED | / | / | ||||
380 | 44/F | CR | yes | |||||
CR | / | |||||||
393 | 54/M | CR | CR | / | yes | / | ||
399 | 23/F | ED | / | / | ||||
401 | 69/M | RD | / | / | ||||
403 | 73/F | RD | / | / | ||||
412 | 46/M | RD | / | / | ||||
418 | 62/F | CR | CR | / | ||||
423 | 43/M | ED | / | / | ||||
426 | 56/M | ED | / | / | ||||
469 | 63/M | CR | CR | yes | / | |||
487 | 73/M | RD | RD | |||||
556 | 50/M | ED | / | / | ||||
612 | 30/M | CR | CR | / | ||||
615 | 40/F | CR | CR | / | ||||
645 | 43/F | RD | / | / | ||||
672 | 33/F | RD | / | |||||
680 | 67/M | ED | / | / |
Parameter | Total (n = 110) | |||
---|---|---|---|---|
Male (%) | 62 (56.4) | 13 (21) | 49 (79) | |
Female (%) | 48 (43.6) | 12 (25) | 36 (75) | |
53.5(19-78) | 50(23-73) | 54(19-78) | 0.783 | |
0.081 | ||||
Yes | 45(40.9) | 14(31.1) | 31 (68.9) | |
No | 65(59.1) | 11(16.9) | 54 (83.1) | |
Yes | 8(7.3) | 3 (37.5) | 5 (62.5) | |
No | 102(92.7) | 22(21.6) | 80(78.4) | |
16.8 (0.5-195) | 6.9 (0.5-160) | 17.4 (0.8-195) | 0.373 | |
median, range | 95.5 (6-178) | 100 (57-178) | 94 (6-140) | 0.810 |
median, range | 68 (1-420) | 109(16-193) | 56 (1-420) | 0.024 |
917 (273-7180) | 901 (315-5105) | 922.5 (273-7180) | 0.825 | |
26 (0-96) | 60.5 (0-96) | 21 (0-96) | 0.031 | |
71 (23-97) | 67 (33-97) | 73 (23-97) | 0.920 | |
0.139 | ||||
M0 | 10 | 4 (40) | 6 (60) | |
M1 | 22 | 6 (27.3) | 16(72.7) | |
M2 | 31 | 9 (29) | 22 (71) | |
M4 | 24 | 5 (21) | 19 (79) | |
M5 | 22 | 1 (0.05) | 21 (95.5) | |
M6 | 1 | 0 (0.0) | 1 (100.0) | |
0.626 | ||||
present (%) | 26(23.6) | 5 (19.2) | 21 (80.8) | |
absent (%) | 84(76.4) | 20 (23.8) | 64 (76.2) | |
0.428 | ||||
present (%) | 9 | 3 (33.3) | 6 (66.7) | |
absent (%) | 101 | 22 (21.8) | 79 (78.2) | |
0.496 | ||||
present (%) | 42(38.2) | 11(26.2) | 31(73.8) | |
absent (%) | 68(61.8) | 14(20.6) | 54(79.4) |
Mutation | Nucleotide change | Amino acid change | No. of patients |
---|---|---|---|
c.394C>T | R132C | 4 | |
c.395G>A | R132H | 2 | |
c.394C>G | R132G | 1 | |
c.394C>A | R132S | 1 | |
c.419G>A | R140Q | 12 | |
c.418C>T | R140W | 1 | |
c.419G>T | R140L | 1 | |
c.418C>G | R140G | 1 | |
c.515G>A | R172K | 2 |